1. Wang Y#, Zhang L#, Sang L#, Ye F# et al, Kinetics of viral load and antibody response in relation to
COVID-19 severity. Journal of Clinical Investigation. 2020.
2. Yanqun Wang#, Daxi Wang#, Lu Zhang#, et al, Intra-host Variation and Evolutionary Dynamics of
SARS-CoV-2 Populations in COVID-19 Patients. Genome Medicine, 2021.
3. Wang Y#, Li X#, Liu W#, et al, Discovery of a subgenotype of human coronavirus NL63 associated
with severe lower respiratory tract infection in China, 2018. Emerg Microbes Infect. 2020.
4. Zhong H#, Wang Y#, Shi Z#, et al, Characterization of respiratory microbial dysbiosis in
hospitalized COVID-19 patients. Cell Discov. 2021.
5. Zhang Z#, Liu W#, et al, Wang Y*, Zhao J*. Two novel human coronavirus OC43 genotypes
circulating in hospitalized children with pneumonia in China. Emerg Microbes Infect. 2022.
6. Zhaoyong Zhang#, Eric Zeng#, Lu Zhang#, et al, Yanqun Wang*, Weihui Shao*, Jincun Zhao*.
Potent Prophylactic and Therapeutic Efficacy of Recombinant Human ACE2-Fc against SARS-CoV-2
Infection in Vivo. Cell Discov. 2021.
7. Wang Y#, Li J#, Zhang L#, et al, Plasma cell-free RNA characteristics in COVID-19 patients.
Genome Res. 2022.
8. Du Y#, Zhang S#, et al, Wang Y*, Zhao J*. Intranasal Lentiviral Vector-Mediated Antibody
Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice. Front
Immunol. 2022.
9. Wang Y#, Sun J#, Li X#, Zhu A#, et al, Increased Pathogenicity and Virulence of Virus in Middle
East Respiratory Syndrome Coronavirus Clade B in Vitro and in Vivo. Journal of Virology. 2020.
10. Wang Y#, Zhan W#, Liu J#, Wang Y#, et al, A broadly neutralizing antibody against SARS-CoV-2
Omicron variant infection exhibiting a novel trimer dimer conformation in spike protein binding. Cell Res.
2022.
代表性成果: